FDA Inspection 1101464 — Merck & Co. Inc

Merck & Co. Inc — FEI 2211017

The FDA completed an inspection of Merck & Co. Inc on September 6, 2019 in Rahway, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 6, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Rahway, NJ (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
755721 CFR 312.56(b)Notification of FDA of termination of investigator